Given the promise of BCL-2 inhibitors in enhancing death of HIV infected cells, we assessed whether BCL-2 inhibition could enhance the ability of CD8 T cells and NK cells to kill acutely HIV-infected CD4 cells, and if those effects translated into meaningful changes in HIV dynamics and reservoir establishment in a humanized mouse model of acute HIV infection. The gene discussed is CD8A; the disease is HIV infectious disease.